This award highlights Naru's commitment to innovation and new technologies with the aim of improving the healthcare system. The tool guarantees the collection of data and the obtaining of valuable information without hospitals losing control and ownership of the data.

In addition to the company Naru, two other projects have been awarded. The UK company Novai has received the award in the ophthalmology category for the development of a biomarker based on artificial intelligence (AI) to predict the progression of glaucoma and age-related macular degeneration (AMD). In the hospital field, the award-winning initiative has been NaIA-DMAE, from the University Hospital of Navarra, an AI tool that automatically detects and measures retinal fluid in patients with AMD and diabetic macular edema (DME).

A consolidated company with a new visual identity from artificial intelligence.

Naru transforms clinical data management for use in different areas of the therapeutic value chain. It is the only validated solution in Europe that generates Real World Evidence (RWE) in real time and combining PROs (Patient Reported Outcomes) and HIS (Hospital Information System) to enhance strategic decision-making. Thanks to its own Aiatech technology and its Step Oncology technological tool, this new care environment contributes to the improvement and optimization of clinical practice, research and the patient's life.

The new version of the Step Oncology tool connects directly with the institutions that manage clinical trials and treatments. Patients can easily report symptoms, side effects of treatments and their health status without having to go to hospitals and from their own mobile phone. The application not only makes life easier for patients, it also allows healthcare professionals to obtain a more complete and constant view of how each person is progressing between medical visits. Especially in the case of cancer patients, where treatments can have very variable effects, this type of monitoring is key to accurately adjusting care and attention. In addition, the information provided by patients is protected, completely preserving privacy and guaranteeing the confidentiality of medical data.